Presentation is loading. Please wait.

Presentation is loading. Please wait.

The diagram shows the manner in which remodeling can modify the cross-sections of blood vessels. The diagram shows the manner in which remodeling can modify.

Published bySudomo Santoso Modified over 5 years ago

Similar presentations

Presentation on theme: "The diagram shows the manner in which remodeling can modify the cross-sections of blood vessels. The diagram shows the manner in which remodeling can modify."— Presentation transcript:

1 The diagram shows the manner in which remodeling can modify the cross-sections of blood vessels.
The diagram shows the manner in which remodeling can modify the cross-sections of blood vessels. The starting point is the vessel at the center (shaded). Remodeling can be hypertrophic (e.g., doubling of cross-sectional area, vessels in the right column), eutrophic (no change in cross-sectional area, vessels in the center column), or hypotrophic (halving of the cross-sectional area, vessels in the left column). These forms of remodeling can be inward (e.g., 30% reduction in lumen diameter, vessel in the top row) or outward (e.g., 30% increase in lumen diameter, vessels in the bottom row). Reprinted from reference (23), with permission. Arif Asif et al. CJASN 2006;1: ©2006 by American Society of Nephrology

Download ppt "The diagram shows the manner in which remodeling can modify the cross-sections of blood vessels. The diagram shows the manner in which remodeling can modify."

Similar presentations

Chapter 1 Section 1.6 Algebraic Properties of Matrix Operations.

Chapter 1 Section 1.6 Algebraic Properties of Matrix Operations.
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Volume 70, Issue 8, Pages (October 2006)

Volume 70, Issue 8, Pages (October 2006)
Mechanism by which negative sodium and water balance may improve myocardial and renal function in CHF. [Reprinted from J Am Coll Cardiol, vol. 47, Schrier.

Mechanism by which negative sodium and water balance may improve myocardial and renal function in CHF. [Reprinted from J Am Coll Cardiol, vol. 47, Schrier.
A case with near-occlusion with full collapse, reprinted with permission from Fox et al.1 Lateral common carotid angiogram shows the thin, threadlike,

A case with near-occlusion with full collapse, reprinted with permission from Fox et al.1 Lateral common carotid angiogram shows the thin, threadlike,
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.
DCT-CA-SPAK decreases Rhcg expression and H-ATPase apical polarization in the inner stripe of the outer medulla. DCT-CA-SPAK decreases Rhcg expression.

DCT-CA-SPAK decreases Rhcg expression and H-ATPase apical polarization in the inner stripe of the outer medulla. DCT-CA-SPAK decreases Rhcg expression.
PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Box plots showing the relative difference in distribution of mtDNA copy number per cell between patients with ESRD and healthy control subjects frequency.

Box plots showing the relative difference in distribution of mtDNA copy number per cell between patients with ESRD and healthy control subjects frequency.
Within-group comparisons of adjusted mean±SEM of absolute change in peak systolic strain (%) from baseline to 12 months using the American Heart Association.

Within-group comparisons of adjusted mean±SEM of absolute change in peak systolic strain (%) from baseline to 12 months using the American Heart Association.
KHA and response. KHA and response. KHA includes AKI history, BP, CKD, serum Creatinine level, Drug list, and urine Dipstick (ABCD). Exposures include.

KHA and response. KHA and response. KHA includes AKI history, BP, CKD, serum Creatinine level, Drug list, and urine Dipstick (ABCD). Exposures include.
Study of isolated perfused tubular segments allowed study of each of the different nephron segments independently. Study of isolated perfused tubular segments.

Study of isolated perfused tubular segments allowed study of each of the different nephron segments independently. Study of isolated perfused tubular segments.
Sample timeline for disaster preparation and response.

Sample timeline for disaster preparation and response.
Urea-PAGE of transferrin incubating for varying times with 100 μg/ml iron gluconate (left) or iron sucrose (right). Urea-PAGE of transferrin incubating.

Urea-PAGE of transferrin incubating for varying times with 100 μg/ml iron gluconate (left) or iron sucrose (right). Urea-PAGE of transferrin incubating.
Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.

Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.
Drug levels during the course of a dosing interval.

Drug levels during the course of a dosing interval.
Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)

Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)
Distribution of podocyte gene mutations in patients with genetic congenital nephrotic syndrome (CNS) and steroid–resistant nephrotic syndrome (SRNS). Distribution.

Distribution of podocyte gene mutations in patients with genetic congenital nephrotic syndrome (CNS) and steroid–resistant nephrotic syndrome (SRNS). Distribution.

Similar presentations

Ads by Google